Elsevier and JAMA Network sign strategic content agreement for ClinicalKey AI

Elsevier, a global leader in advanced information and analytics, today announced a strategic content agreement with the JAMA Network that brings full-text content and visuals from the JAMA Network Family of Journals to ClinicalKey AI, the company’s clinical grade AI workspace. The addition of the JAMA Network’s specialty journals further deepens a content collection that already spans leading journals and medical society publications worldwide, giving clinicians full-text access to more than half of the world’s top 100 medical journals.

Under the agreement, all published full-text content and visuals from 13 journals — including JAMA, JAMA Network Open and 11 specialty journals (JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology–Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery) — will inform the responses clinicians receive through ClinicalKey AI.

Clinicians face growing volumes of published evidence and reduced time in which to apply clinical insights. ClinicalKey AI is designed to close that gap by grounding every answer in peer-reviewed, evidence-based sources and linking clinicians directly to the full-text articles behind it.

Omry Bigger, President, Clinical Solutions, Elsevier, said: “Clinicians tell us that trust is the deciding factor in whether they will use AI at the point of care. This strategic content agreement with the JAMA Network means that when a clinician uses ClinicalKey AI, the answer can draw on many years of prestigious evidence-based content from JAMA journals without compromising privacy and security. We look forward to our strong collaboration with the JAMA Network and bringing the best insights and clinical content directly into the hands of clinicians at the point of care.”

Brian Shields, Group Vice President and Publisher of JAMA and the JAMA Network said: “The research published across the JAMA Network is intended to help inform clinical decisions at the bedside, in the clinic and in the exam room, Working with a global information and analytics leader like Elsevier extends the reach of that evidence to clinicians in the moments they need it most, with the full article always a click away so they can see the study, the methods and the context behind any answer.”

Built for health systems

ClinicalKey AI is deployed by health systems that require both credible content, precision AI and enterprise-grade technology. Access to JAMA Network journals and other evidence-based information is delivered securely and compliantly, with capabilities including:

• API-based integration options, including compatibility with existing workflow tools.

• Support for HIPAA-compliant use in North America, with privacy and security controls built to help protect patient health information (PHI).

• A new deep research assistant that allows clinicians to take a deeper dive into clinical topics.

• Multi-language support and prompt sharing.

• Coming soon: Following the recent acquisition of WellSheet, ClinicalKey AI will offer deeper integration into hospital systems’ electronic health records to deliver patient context and trusted clinical information to clinicians.

Content from the JAMA Network journals is available to ClinicalKey AI customers now.

About Elsevier

エルゼビアは、先端情報と意思決定支援の分野におけるグローバルリーダーです。1世紀以上にわたり、科学と医療の発展を通じて人類の進歩に貢献してきました。世界170か国において、学術・企業の研究コミュニティ、医師、看護師、将来の医療従事者、教育関係者の重要な活動を支援しています。エルゼビアは、世界有数のエビデンスに基づく科学・医学コンテンツ、精度の高いAI、そして専門家による評価を基盤とした研究・臨床レベルのソリューションを提供し、より良い成果の実現を支援しています。また、サービスを提供するコミュニティと連携しながら、多様性とサステナビリティの推進にも取り組んでいます。エルゼビア財団opens in new tab/window（Elsevier Foundation）は、世界各地における研究および医療分野のパートナーシップを支援しています。

エルゼビアは、専門家およびビジネス向けの情報分析および意思決定ツールを提供するグローバル企業、RELXopens in new tab/windowの一員です。詳細については、https://www.elsevier.com/ja-jp をご覧いただくか、ソーシャルメディアの @elsevierconnect をご参照ください。